Elizabeth A. Amin

751 total citations
32 papers, 639 citations indexed

About

Elizabeth A. Amin is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Elizabeth A. Amin has authored 32 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Genetics. Recurrent topics in Elizabeth A. Amin's work include Bacillus and Francisella bacterial research (6 papers), Chemical Synthesis and Analysis (5 papers) and Computational Drug Discovery Methods (5 papers). Elizabeth A. Amin is often cited by papers focused on Bacillus and Francisella bacterial research (6 papers), Chemical Synthesis and Analysis (5 papers) and Computational Drug Discovery Methods (5 papers). Elizabeth A. Amin collaborates with scholars based in United States, Hungary and China. Elizabeth A. Amin's co-authors include Donald G. Truhlar, William J. Welsh, Anastassia Sorkin, Peter I. Dosa, Ting-Lan Chiu, Philippe Bühlmann, Hannah R. Leverentz, József Rábai, Khyatiben V. Pathak and Carston R. Wagner and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and FEBS Letters.

In The Last Decade

Elizabeth A. Amin

32 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth A. Amin United States 13 211 167 102 96 89 32 639
Pandian Sokkar Germany 13 220 1.0× 215 1.3× 114 1.1× 54 0.6× 43 0.5× 22 688
Gábor Paragi Hungary 16 482 2.3× 170 1.0× 86 0.8× 96 1.0× 44 0.5× 55 810
Chia‐Ning Yang Taiwan 16 304 1.4× 278 1.7× 77 0.8× 217 2.3× 48 0.5× 54 857
R.J. Rosenfeld United States 14 480 2.3× 123 0.7× 109 1.1× 42 0.4× 55 0.6× 15 1.0k
Raquel Castillo Spain 17 329 1.6× 312 1.9× 121 1.2× 109 1.1× 29 0.3× 49 776
Anmol Kumar United States 14 176 0.8× 175 1.0× 120 1.2× 151 1.6× 31 0.3× 32 599
Sourav Pal India 12 221 1.0× 433 2.6× 156 1.5× 128 1.3× 59 0.7× 19 830
Eric T. Mack United States 10 407 1.9× 169 1.0× 91 0.9× 58 0.6× 43 0.5× 13 622
Sylvain Clède France 13 193 0.9× 224 1.3× 172 1.7× 27 0.3× 187 2.1× 17 709
Jeffrey W. Lockman United States 12 271 1.3× 372 2.2× 92 0.9× 191 2.0× 54 0.6× 19 848

Countries citing papers authored by Elizabeth A. Amin

Since Specialization
Citations

This map shows the geographic impact of Elizabeth A. Amin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Amin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Amin more than expected).

Fields of papers citing papers by Elizabeth A. Amin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth A. Amin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Amin. The network helps show where Elizabeth A. Amin may publish in the future.

Co-authorship network of co-authors of Elizabeth A. Amin

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth A. Amin. A scholar is included among the top collaborators of Elizabeth A. Amin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth A. Amin. Elizabeth A. Amin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Rodney L., et al.. (2015). Ligand‐induced expansion of the S1′ site in the anthrax toxin lethal factor. FEBS Letters. 589(24PartB). 3836–3841. 3 indexed citations
2.
Dosa, Peter I. & Elizabeth A. Amin. (2015). Tactical Approaches to Interconverting GPCR Agonists and Antagonists. Journal of Medicinal Chemistry. 59(3). 810–840. 34 indexed citations
3.
Zhang, Xia & Elizabeth A. Amin. (2015). Highly predictive support vector machine (SVM) models for anthrax toxin lethal factor (LF) inhibitors. Journal of Molecular Graphics and Modelling. 63. 22–28. 7 indexed citations
4.
Geders, Todd W., Dong‐Jin Hwang, Michael A. Walters, et al.. (2014). Anthrax toxin lethal factor domain 3 is highly mobile and responsive to ligand binding. Acta Crystallographica Section D Biological Crystallography. 70(11). 2813–2822. 12 indexed citations
5.
Zhang, Xia, et al.. (2014). Statistical Analysis, Optimization, and Prioritization of Virtual Screening Parameters for Zinc Enzymes Including the Anthrax Toxin Lethal Factor. Current Topics in Medicinal Chemistry. 14(18). 2105–2114. 1 indexed citations
6.
7.
Leverentz, Hannah R., et al.. (2011). Electrostatically Embedded Many-Body Expansion for Neutral and Charged Metalloenzyme Model Systems. Journal of Chemical Theory and Computation. 8(1). 1–5. 20 indexed citations
8.
9.
Jia, Yan, Ting-Lan Chiu, Elizabeth A. Amin, et al.. (2009). Design, synthesis and evaluation of analogs of initiation factor 4E (eIF4E) cap-binding antagonist Bn7-GMP. European Journal of Medicinal Chemistry. 45(4). 1304–1313. 41 indexed citations
10.
Hutt, Oliver E., Sajiv K. Nair, John T. Henri, et al.. (2009). Total synthesis and evaluation of 22-(3-azidobenzoyloxy)methyl epothilone C for photoaffinity labeling of β-tubulin. Bioorganic & Medicinal Chemistry Letters. 19(12). 3293–3296. 4 indexed citations
11.
Hutt, Oliver E., Sajiv K. Nair, John T. Henri, et al.. (2008). Total synthesis and evaluation of C25-benzyloxyepothilone C for tubulin assembly and cytotoxicity against MCF-7 breast cancer cells. Bioorganic & Medicinal Chemistry Letters. 18(17). 4904–4906. 6 indexed citations
12.
Bühlmann, Philippe, et al.. (2008). Assessment of density functionals, semiempirical methods, and SCC-DFTB for protonated creatinine geometries. Journal of Molecular Structure THEOCHEM. 861(1-3). 68–73. 12 indexed citations
13.
Amin, Elizabeth A. & William J. Welsh. (2006). A Preliminary in Silico Lead Series of 2-Phthalimidinoglutaric Acid Analogues Designed as MMP-3 Inhibitors. Journal of Chemical Information and Modeling. 46(5). 2104–2109. 11 indexed citations
14.
Amin, Elizabeth A. & William J. Welsh. (2006). Highly Predictive CoMFA and CoMSIA Models for Two Series of Stromelysin-1 (MMP-3) Inhibitors Elucidate S1‘ and S1−S2‘ Binding Modes. Journal of Chemical Information and Modeling. 46(4). 1775–1783. 15 indexed citations
15.
Amin, Elizabeth A., Wesley R. Harris, & William J. Welsh. (2003). Identification of possible kinetically significant anion‐binding sites in human serum transferrin using molecular modeling strategies. Biopolymers. 73(2). 205–215. 10 indexed citations
16.
Flynn, Michael B., Elizabeth A. Amin, & Roy C. Martin. (1998). Mobile mammography screening: the James Graham Brown Cancer Center three year experience. Implications for public and professional education.. PubMed. 96(1). 17–20. 2 indexed citations
17.
Amin, Elizabeth A. & Mohammad Amin. (1992). Comparison of the Cost-Effectiveness of Various Therapies for Common Prostatic Disorders. PharmacoEconomics. 1(5). 357–369. 6 indexed citations
18.
Spratt, John S., Richard A. Greenberg, James G. Kuhns, & Elizabeth A. Amin. (1989). Breast cancer risk: A review of definitions and assessments of risk. Journal of Surgical Oncology. 41(1). 42–46. 5 indexed citations
19.
Amin, Elizabeth A., et al.. (1987). Bipartite Liver A Case Report. Clinical Nuclear Medicine. 12(8). 641–643. 3 indexed citations
20.
Thind, Gurdarshan S., et al.. (1984). Enhancement of renal venous renin ratios by intravenous hydralazine in renovascular hypertension. The American Journal of Cardiology. 53(1). 109–115. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pandian Sokkar Breakdown of academic impact, for papers by Gábor Paragi Breakdown of academic impact, for papers by Chia‐Ning Yang Breakdown of academic impact, for papers by R.J. Rosenfeld Breakdown of academic impact, for papers by Raquel Castillo Breakdown of academic impact, for papers by Anmol Kumar Breakdown of academic impact, for papers by Sourav Pal Breakdown of academic impact, for papers by Eric T. Mack Breakdown of academic impact, for papers by Sylvain Clède Breakdown of academic impact, for papers by Jeffrey W. Lockman
Rankless by CCL
2026